ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001

Consensus conference On Cervical Cancer

January 26, 1996

Small Business Technology Transfer Program Solicitation

June 23, 1995